이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Applied Therapeutics 관리
관리 기준 확인 1/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Shoshana Shendelman
최고 경영자
US$9.5m
총 보상
| CEO 급여 비율 | 6.6% |
| CEO 임기 | 8.8yrs |
| CEO 소유권 | 4.0% |
| 경영진 평균 재임 기간 | less than a year |
| 이사회 평균 재임 기간 | 7.7yrs |
최근 관리 업데이트
Recent updates
Applied Therapeutics: FDA Stance Change For Advisory Panel Bodes Well For Review
Sep 18Applied Therapeutics: Pushing Towards FDA Approval
Sep 04We're Hopeful That Applied Therapeutics (NASDAQ:APLT) Will Use Its Cash Wisely
Aug 01
Applied Therapeutics: Navigating Challenges In ARI Development For Rare Diseases
May 28Applied Therapeutics: Speedy Regulatory Review Of Govorestat Might Be Possible
Feb 16Is Applied Therapeutics (NASDAQ:APLT) In A Good Position To Deliver On Growth Plans?
Feb 16Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?
Nov 13We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
Aug 11We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate
May 19Applied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's Stock
Jan 19Is Applied Therapeutics (NASDAQ:APLT) Using Debt In A Risky Way?
Nov 11Here's Why We're Watching Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation
Aug 13Applied Therapeutics trades higher on FDA Fast Track designation for rare metabolic disorder
Jun 17Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?
May 15Independent Director Stacy Kanter Just Bought 100% More Shares In Applied Therapeutics, Inc. (NASDAQ:APLT)
Feb 26How Much Of Applied Therapeutics, Inc. (NASDAQ:APLT) Do Insiders Own?
Feb 18Applied Therapeutics to resume galactosemia study for AT-007
Feb 02Applied Therapeutics, Inc. (NASDAQ:APLT) Insiders Have Been Selling
Nov 24
Applied Therapeutics EPS misses by $0.21
Nov 12CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$161m |
| Mar 31 2024 | n/a | n/a | -US$194m |
| Dec 31 2023 | US$9m | US$630k | -US$120m |
| Sep 30 2023 | n/a | n/a | -US$97m |
| Jun 30 2023 | n/a | n/a | -US$73m |
| Mar 31 2023 | n/a | n/a | -US$70m |
| Dec 31 2022 | US$3m | US$588k | -US$83m |
| Sep 30 2022 | n/a | n/a | -US$95m |
| Jun 30 2022 | n/a | n/a | -US$105m |
| Mar 31 2022 | n/a | n/a | -US$105m |
| Dec 31 2021 | US$2m | US$588k | -US$106m |
| Sep 30 2021 | n/a | n/a | -US$102m |
| Jun 30 2021 | n/a | n/a | -US$104m |
| Mar 31 2021 | n/a | n/a | -US$106m |
| Dec 31 2020 | US$5m | US$578k | -US$94m |
| Sep 30 2020 | n/a | n/a | -US$88m |
| Jun 30 2020 | n/a | n/a | -US$69m |
| Mar 31 2020 | n/a | n/a | -US$49m |
| Dec 31 2019 | US$12m | US$550k | -US$46m |
| Sep 30 2019 | n/a | n/a | -US$35m |
| Jun 30 2019 | n/a | n/a | -US$28m |
| Mar 31 2019 | n/a | n/a | -US$23m |
| Dec 31 2018 | US$1m | US$500k | -US$17m |
보상 대 시장: Shoshana 의 총 보상 ($USD 9.49M )은 US 시장( $USD 2.46M ).
보상과 수익: 회사가 수익성이 없는 동안 Shoshana 의 보상이 증가했습니다.
CEO
Shoshana Shendelman (45 yo)
8.8yrs
테뉴어
US$9,493,213
보상
Dr. Shoshana Shendelman, PhD, has been Director of Applied Therapeutics Inc. since January 2016. Prior to founding Applied, she founded Clearpoint Strategy Group, a boutique life science consulting firm, w...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chair of the Board of Directors | no data | US$9.49m | 3.96% $ 38.7m | |
| CFO, Principal Financial Officer & Independent Director | less than a year | US$675.15k | 0.079% $ 768.5k | |
| Chief Medical Officer | 6.2yrs | US$3.04m | 0.15% $ 1.4m | |
| COO & Chief Business Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Accounting Officer | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Chief Commercial Officer | less than a year | 데이터 없음 | 데이터 없음 |
0.9yrs
평균 재임 기간
57.5yo
평균 연령
경험이 풍부한 관리: APLT 의 관리팀은 경험 (평균 재직 기간 0.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Chair of the Board of Directors | 8.8yrs | US$9.49m | 3.96% $ 38.7m | |
| CFO, Principal Financial Officer & Independent Director | 8.3yrs | US$675.15k | 0.079% $ 768.5k | |
| Independent Director | 7.8yrs | US$85.65k | 0.39% $ 3.9m | |
| Independent Director | 5.5yrs | US$92.53k | 0.017% $ 170.0k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Lead Independent Director | 7.6yrs | US$88.78k | 0.053% $ 513.6k | |
| Independent Director | 5.4yrs | US$94.40k | 0.055% $ 535.5k | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Chairman of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 |
7.7yrs
평균 재임 기간
68yo
평균 연령
경험이 풍부한 이사회: APLT 의 이사회는 경험(평균 재직 기간 7.3 년)으로 간주됩니다.